
Biogen (NASDAQ: BIIB) has announced that the European Medicines Agency (EMA) has accepted its investigational treatment for Alzheimer’s disease, aducanumab, …

The European Medicines Agency (EMA) has launched its new PRIME (priority medicines) scheme, which aims to strengthen support to medicines …

The PM Society is set to expand its reach across pharma and service firms through the new appointments of co-chairs …
The times they are a changin’ and not just according to Bob Dylan. It’s hard to go to any UK …
Marketing is defined in the New English Dictionary as all the processes involved in moving goods from the producer to …

